Want to see AU:NAN full AI Analyst Report?
NAN Stock Chart & Stats
AU$3.05
AU$0.01(0.34%)
At close: 4:00 PM EDT
AU$3.05
AU$0.01(0.34%)
Day’s Range― - ―
52-Week RangeAU$2.64 - AU$4.71
Previous CloseN/A
Volume249.34K
Average Volume (3M)999.85K
Market Cap
AU$897.50M
Enterprise ValueAU$896.46M
Total Cash (Recent Filing)AU$155.22M
Total Debt (Recent Filing)AU$23.13M
Price to Earnings (P/E)51.5
Beta0.37
Next Earnings
Feb 23, 2027EPS Estimate
0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.06
Shares Outstanding299,167,630
10 Day Avg. Volume1,065,085
30 Day Avg. Volume999,850
Financial Highlights & Ratios
PEG Ratio-4.18
Price to Book (P/B)4.63
Price to Sales (P/S)4.95
P/FCF Ratio57.84
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$3.72Price Target Upside21.86% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)0.03
Revenue Forecast (FY)AU$219.53M
Bulls Say, Bears Say
Bulls Say
Installed-base Annuity GrowthA growing installed base supports recurring consumables and service revenue, making the trophon ecosystem less dependent on one-time equipment sales. Continued placements, upgrades and utilisation can compound this annuity stream and improve revenue visibility over the next several quarters.
CORIS Expansion PlatformRegulatory clearance across major markets materially expands Nanosonics’ addressable opportunity beyond trophon. CORIS also has higher stated pricing, cycle volumes and service take-rates, creating the potential for a meaningful second growth engine as commercial adoption develops.
Conservative Balance SheetA debt-free balance sheet and substantial cash reserve provide flexibility to fund CORIS commercialisation, product development and facility expansion without relying on external financing. Strong trophon cash generation also supports resilience and shareholder returns while new investments mature.
Bears Say
Margin CompressionThe decline in net and gross margins indicates that recent revenue has converted into less profit than at the prior peak. Product mix, currency and cost pressures could continue limiting operating leverage, reducing the earnings benefit from future sales growth.
Weaker Cash ConversionLower operating and free cash flow relative to accounting earnings points to weaker cash conversion and less predictable funding capacity. If this persists, Nanosonics may have less internally generated cash for investment, buybacks and expansion despite remaining profitable.
CORIS Launch Cost BurdenCORIS is expected to require substantial commercial investment before generating material revenue, creating near-term earnings dilution and weaker cost absorption. The resulting payoff depends on adoption accelerating beyond the launch year, leaving execution and timing risk over the next several quarters.
Nanosonics Limited News
NAN FAQ
What was Nanosonics Limited’s price range in the past 12 months?
Nanosonics Limited lowest share price was AU$2.64 and its highest was AU$4.71 in the past 12 months.
What is Nanosonics Limited’s market cap?
Nanosonics Limited’s market cap is AU$897.50M.
When is Nanosonics Limited’s upcoming earnings report date?
Nanosonics Limited’s upcoming earnings report date is Feb 23, 2027 which is in 124 days.
How were Nanosonics Limited’s earnings last quarter?
Nanosonics Limited released its earnings results on Aug 24, 2026. The company reported AU$0.029 earnings per share for the quarter, beating the consensus estimate of AU$0.025 by AU$0.004.
Is Nanosonics Limited overvalued?
According to Wall Street analysts Nanosonics Limited’s price is currently Undervalued.
Does Nanosonics Limited pay dividends?
Nanosonics Limited does not currently pay dividends.
What is Nanosonics Limited’s EPS estimate?
Nanosonics Limited’s EPS estimate is 0.02.
How many shares outstanding does Nanosonics Limited have?
Nanosonics Limited has 299,167,630 shares outstanding.
What happened to Nanosonics Limited’s price movement after its last earnings report?
Nanosonics Limited reported an EPS of AU$0.029 in its last earnings report, beating expectations of AU$0.025. Following the earnings report the stock price went down -17.12%.
Which hedge fund is a major shareholder of Nanosonics Limited?
Currently, no hedge funds are holding shares in AU:NAN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Nanosonics Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$3.72 (21.86% Upside)
AU$3.72 (21.86% Upside)
Blogger Sentiment
Bullish
AU:NAN Sentiment 100%
Sector Average 67%
Sector Average 67%
Insider Transactions
Bought Shares
Worth AU$133.2K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-40.25%
12-Months-Change
Fundamentals
Return on Equity
8.16%
Trailing 12-Months
Asset Growth
18.98%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Nanosonics Limited
Nanosonics Limited, along with its subsidiaries, functions as a global infection prevention enterprise with operations in Australia and beyond. The company focuses on the production and distribution of its trophon ultrasound probe disinfection system, including all related supplies and accessories. Additionally, it dedicates resources to the exploration, development, and market launch of innovative infection control, decontamination products, and their associated technologies. Key offerings from Nanosonics include trophon2, an advanced device for high-level disinfection of ultrasound probes; trophon EPR, a low-temperature, high-level disinfection method specifically for intra-cavity ultrasound probes; and Nanosonics AuditPro, a comprehensive solution for managing compliance with infection control workflows. Established in 2000, Nanosonics Limited is headquartered in Macquarie Park, Australia.
NAN Company Deck
NAN Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a predominantly positive operational and financial picture: constant-currency revenue and EBIT growth, strong trophon profitability and cash generation, record placements and upgrades, product innovation (trophon3/trophon2 Plus), solid annuity and service growth, a debt-free balance sheet with substantial cash and an active buyback. Management also delivered substantial regulatory and commercial progress for CORIS and set explicit FY'27 guidance that anticipates continued growth. Negative items are present but largely manageable and/or transitional: a Q3 consumables dip due to weather, margin moderation from product mix and currency, APAC softness tied to rental models, and elevated near-term OpEx to fund CORIS commercialization which will weigh on near-term profitability. Overall, highlights substantially outweigh the lowlights, with CORIS viewed as a meaningful long-term growth opportunity while trophon continues as a strong cash engine.View all AU:NAN earnings summariesNAN Stock 12 Month Forecast
Average Price Target
AU$3.72
▲(21.86% Upside)
Technical Analysis
Ansell
―
Polynovo
―
Paragon Care Limited
―
Trajan Group Holdings Ltd
―
CleanSpace Holdings Ltd.
―